Frequency and predictors of De Novo hepatocellular carcinoma in patients awaiting orthotopic liver transplantation during the model for end-stage liver disease era

Liver Transplantation

Volumn 14, Issue 2, 2008, Pages 228-234

  Brady, Carla W ^a,b   Smith, Alastair D ^b   Stechuchak, Karen M ^a   Coffman, Cynthia J ^a,c   Tuttle Newhall, Janet E ^b   Provenzale, Dawn ^a,b   Muir, Andrew J ^b  

^a DURHAM VA MEDICAL CENTER   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; ALCOHOL LIVER DISEASE; ARTICLE; ASIAN; CANCER RISK; CANCER SCREENING; CONTROLLED STUDY; FEMALE; HEPATITIS B; HEPATITIS C; HOSPITAL ADMISSION; HUMAN; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; RACE DIFFERENCE; SENSITIVITY ANALYSIS; SEX DIFFERENCE;

AGE FACTORS; ASIAN CONTINENTAL ANCESTRY GROUP; CARCINOMA, HEPATOCELLULAR; ETHNIC GROUPS; FEMALE; HEPATITIS B; HEPATITIS C; HUMANS; LIVER DISEASES, ALCOHOLIC; LIVER NEOPLASMS; LIVER TRANSPLANTATION; LOGISTIC MODELS; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; ODDS RATIO; RISK ASSESSMENT; RISK FACTORS; SEX FACTORS; TIME FACTORS; TISSUE AND ORGAN PROCUREMENT; UNITED STATES; WAITING LISTS;

EID: 39449120489     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.21346     Document Type: Article

References (18)

1. Bosch FX, Ribes J, Diaz M, Cléries R. Primary liver cancer: worldwide incidence and trends. Gastroenterology 2004; 127:S5-S16.
2. El-Serag HB, Mason AC. Rising incidence of hepatocellular carcinoma in the United States. New Engl J Med 1999; 340:745-750.
3. Varela M, Sanchez W, Bruix J, Gores GJ. Hepatocellular carcinoma in the setting of liver transplantation. Liver Transpl 2006;12:1028-1036.
4. Van Thiel DH, Yong S, Li D, Kennedy M, Brems J. The development of de novo hepatocellular carcinoma in patients on a liver transplant list: frequency, size, and assessment of current screening methods. Liver Transpl 2004;10:631-637.
5. Racial and ethnic classifications used in Census 2000 and beyond. Available at: http://www.census.gov/population/www/socdemo/race/ racefactcb.html. Accessed September 5, 2006.
6. Organ distribution: allocation of livers. Available at: http://www.unos.org/policiesandbylaws2/policies/pdfs/policy_8.pdf. Accessed August 4, 2007
7. Hosmer DW, Lemeshow S. Applied Logistic Regression. 2nd ed. New York: John Wiley & Sons; 2000.
8. Cohen J. Statistical Power Analysis for the Behavioral Sciences. 2nd ed. Hillsdale, NJ: Lawrence Erlbaum Associates; 1988.
9. Allison PD. Logistic Regression Using the SAS® System: Theory and Application. Cary, NC: SAS Institute; 1999.
10. El-Serag HB, Davila JA, Petersen NJ, McGlynn KA. The continuing increase in the incidence of hepatocellular carcinoma in the United States: an update. Ann Intern Med 2003;139:817-823.
11. Reid AE, Resnick M, Chang Y, Buerstatte N, Weissman JS. Disparity in use of orthotopic liver transplantation among blacks and whites. Liver Transpl 2004;10:834-841.
12. El-Serag HB. Hepatocellular carcinoma: recent trends in the United States. Gastroenterology 2004;127:S27-S34.
13. 2005 OPTN/SRTR annual report: adjusted patient survival, deceased donor liver transplants-survival at 3 months, 1 year, 3 years, and 5 years. Available at: http://www.ustransplant.org/annual_reports/current/ 91lali.htm. Accessed November 29, 2006.
14. El-Serag HB, Mason AC. Risk factors for the rising rates of primary liver cancer in the United States. Arch Intern Med 2000;160:3227-3230.
15. Stickel F, Schuppan D, Hahn EG, Seitz HK. Cocarcinogenic effects of alcohol in hepatocarcinogenesis. Gut 2002;51:132-139.
16. Sanyal AJ, Banas C, Sargeant C, Luketic VA, Sterling RK, Stravitz RT, et al. Similarities and differences in outcomes of cirrhosis due to nonalcoholic steatohepatitis and hepatitis C. Hepatology 2006;43:682-689.
17. Banares R, Núnez O, Escudero M, Fernández, Vaquero J, Beceiro I, et al. Patients with cirrhosis and bare-stent TIPS may have increased risk of hepatocellular carcinoma. Hepatology 2005;41:566-571.
18. Freeman PB, Mithoefer A, Ruthazer R, Nguyen K, Schore A, Harper A, et al. Optimizing staging for hepatocellular carcinoma before liver transplantation: a retrospective analysis of the UNOS/OPTN database. Liver Transpl. 2006;12:1504-1511.